Skip to Content

Flunisolide nasal Pregnancy and Breastfeeding Warnings

Flunisolide nasal is also known as: Nasalide, Nasarel

Flunisolide nasal Pregnancy Warnings

Flunisolide has been assigned to pregnancy category C by the FDA. At high doses, flunisolide has been shown to be teratogenic in rabbits and rats. There are no controlled data in human pregnancy. Flunisolide is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

In a review of 229,101 deliveries to Michigan Medicaid patients, 141 first-trimester exposures to flunisolide and 322 exposures anytime during pregnancy were recorded. A total of 5 birth defects were reported with first-trimester exposures (5 expected). (written communication, Franz Rosa, MD, Food and Drug Administration, 1994) These data do not support an association with adverse fetal outcome.

See references

Flunisolide nasal Breastfeeding Warnings

There are no data on the excretion of flunisolide into human milk. Other glucocorticoids are excreted into human milk in low concentrations. The manufacturer recommends that caution be when administering flunisolide nasal to nursing women.

See references

References for pregnancy information

  1. "Product Information. Nasalide (flunisolide)." Syntex Laboratories Inc, Palo Alto, CA.

References for breastfeeding information

  1. "Product Information. Nasalide (flunisolide)." Syntex Laboratories Inc, Palo Alto, CA.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.